-
MannKind Issues Management Update
Monday, January 11, 2016 - 3:44pm | 220Read More...Shares of MannKind Corporation (NASDAQ: MNKD) were trading slightly higher by 1.58 percent at $0.67 mid-Monday afternoon after the company provided an update on its senior management team. MannKind has withdrawn its offer to employ Duane M. DeSisto as its new CEO. The company cited "...
-
MannKind Corporation Sinks: CFO Says 'We're Not There Yet' With Afrezza
Wednesday, June 10, 2015 - 4:30pm | 430Read More...MannKind Corporation (NASDAQ: MNKD) fell more than 7 percent after the company acknowledged it hasn't hit the break-even point for its inhaled insulin product Afrezza. "These low volumes make it painful because the margins aren't there," Chief Financial Officer Matthew J. Pfeffer said at a Goldman...
